Read More

Reported Late Tuesday April 4, Thorne Healthtech Shares Results Of Collaborative Clinical Trial With Mayo Clinic And Healthtech Connex, Inc.; Significant Findings From A Double-blinded, Placebo-Controlled Trial That Measured Brain Function

Significant positive findings from a double-blinded, placebo-controlled trial that measured brain function in ice hockey players over a season NEW YORK, April 4, 2023 /PRNewswire/ -- Thorne HealthTech, Inc.

THRN

Read More

Thorne HealthTech Earnings Preview

Thorne HealthTech (NASDAQ:THRN) is set to give its latest quarterly earnings report on Wednesday, 2022-11-09. Here's what investors need to know before the announcement. Analysts estimate that Thorne HealthTech will report an earnings per share (EPS) of $0.14.

THRN